The G-7 host, Emmanuel Macron, has made fighting inequality the theme for the annual meeting of the seven industrialized nations, which opens Saturday in the French seaside resort of Biarritz with the leaders of the United States, France, Britain, Germany, Italy, Japan and Canada in attendance.
The French president has invited leaders from several other countries, including six African nations, to take part in the annual discussion of major global challenges. But analysts say any grand ambitions for the summit will likely be stymied by pressing economic concerns.
Most worrisome are recent indicators from both sides of the Atlantic of slowing economic growth and a possible global recession.
Earlier this month, government bond yields in both the United States and Germany were briefly higher for two-year than 10-year bonds, a sign that investors see significant risks ahead, says economist Jasper Lawler of the London Capital Group.
“Particularly in the U.S., it’s actually been a very reliable signal to point towards a recession.”
Adding the investors’ fears, the usual fiscal tools to tackle a recession might not be available.
“We don’t have that usual fallback from central banks of cutting interest rates because they already have, and they are already at rock bottom levels,” says Lawler.
The economic fears are rooted in the trade war between the United States and China, which has resulted in both countries imposing tariffs on hundreds of billions of dollars’ worth of imports. Europe is suffering additional headwinds, says economist Lawler.
“The trade war, but also just the auto sector, the transition from using diesel cars to electronic vehicles. It’s a period of uncertainty that’s unduly affecting Europe.”
Summit host France is determined to not let economics overshadow its own agenda — and top of the list is climate change, says John Kirton of the G-7 Research Group at the University of Toronto.
“It’s driven by the scary science which is unfolding every day, but more importantly by the historic heat waves that have afflicted Europe, including France.”
U.S. President Donald Trump left last year’s G-7 summit in Canada early, before the leaders had discussed climate change, and later disavowed the final communiqué. This year France is determined to keep the United States on board, says Kirton.
“President Macron I think has structured his agenda to allow Donald Trump to be at his best. Gender equality — the president has been very good at that, it’s at the top of the French list. Education — yes, and also health. It’s the president of the United States that’s been pushing the G-7 to try to get it to deal with the opioid crisis.”
Security concerns will also be high on the agenda. North Korea has resumed its ballistic missile tests.
Meanwhile the standoff between Iran and the West has escalated over the seizure of a British-flagged oil tanker in the Persian Gulf, which followed the detention of an Iranian vessel in Gibraltar.
Burgeoning anti-government protests in Russia and Hong Kong also pose questions for the G-7, says Kirton.
“Have we seen the tide [change], where authoritarian leaders in various degrees are no longer in control? It may not be the way of the future. In fact, if that’s the case, then how can the G-7 activate its distinctive foundational issue: to promote democracy?” Kirton asked.
Meanwhile British Prime Minister Boris Johnson will meet Trump at the G-7 for the first time in his new role. Both leaders are hoping for a rapid trade deal amid signs of a steep economic downturn in Britain as it edges closer to crashing out of the European Union with no deal at the end of October. (VOA)
As interesting and profitable as marijuana stocks are, they are still mostly penny stocks. This probably has something to do with the fact that making money off of this little green plant is still considered illegal in countries like the United States.
We know some states are changing their laws, but nothing has changed federally just yet. This means investors have to deal with cash most of the time, and sometimes, they can’t take advantage of certain tax deductions. The money made from this industry cannot always be used to open a bank account.
As you can see, there are many obstacles to overcome in this industry.
Some of these factors make it even more important for potential investors to pay attention to the penny stocks they do take a chance on. The following is a list of some of the best penny stocks available today.
1. InMed Pharmaceuticals Inc
When it comes to drug development and commercialization, there are only a few companies that can be compared to this company.
InMed Pharmaceuticals Inc. focuses on Cannabinoids, and they have invested a lot of time and effort into developing the therapeutic aspects of marijuana.
One thing the company is pretty proud of is the bioinformatics assessment tool. This tool allows technicians to figure out if a specific cannabinoid could address certain ailments.
The possibilities with this kind of targeted treatment are endless, which is attracting a number of investors around the globe.
At the moment, it seems like the company has made significant progress towards dealing with Epidermolysis bullosa, glaucoma, and it has also been working hard to address joint and muscle pains.
2. American Cannabis Company Inc.
The American Cannabis Company Inc. is considered the go-to company for entrepreneurs in the United States who are attempting to get into the business of selling marijuana.
Everyone knows that the business is setting itself up for a major boom in the coming years, even though it is already quite profitable.
This company understands that entrepreneurs don't always understand everything there is to know about cannabis, such as marketing it and navigating the current environment surrounding marijuana sales.
The American Cannabis Company Inc. is here to provide counsel, thanks to years of experience in the industry. It is here to provide marketing tools, branding information, and even help with staffing if needed.
The Auxly Cannabis Group is an important company to watch out for. It is considered a cannabis royalty company, and the reason investors should keep an eye on it is because it is focused on helping growers start or expand their capacity.
If the marijuana industry is set to explode as more countries accept its usage, then there is going to be a need for growers who can provide.
Of course, the company does not only help other growers; it has also purchased its own farms as well.
Projections say that these farms may end up producing up to 170,000 kilograms of marijuana in 2019 and the following year. Those kind of numbers have instilled the kind of faith any company wants to instill in possible investors.
4. Plus Products Inc.
Edibles are going to be an important part of the marijuana industry. These little things are fun, and people are loving them. At the moment, Plus Products Inc. is considered one of the fastest growing edible companies.
It continues to produce the kind of edibles that people want, hitting great numbers. Some of their best-selling edibles have seen great staying power and fend off competition.
It is safe to say that this company is putting a lot of work into the products they produce to make sure customers are happy.
It is currently selling its edibles in California, and that means the rest of the country is ripe for the picking, which means the potential for growth is undeniable.
Plus Products Inc. is actually developing an even bigger facility that is going to be able to handle even more orders. It is safe to say that the company is foreseeing a huge spike in demand within the coming months or few short years. Investors interested in the the long game should definitely give this stock a try.
Of course, these are just some of the stocks that investors should keep an eye on, but there are more, such as MariMed Inc. that is more of an all-in-one consulting firm helping dispensaries and other players in the industry. There is also the Aleafia Health stock that focuses on growing and promoting medical cannabis clinics all around the US.
As mentioned earlier, the key here is to make sure each investor pays attention to each stock and what the company is attempting to do. We think one should only invest in a stock when the investor feels he or she can make an informed decision.